Research graph
References from The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Hepatocellular carcinoma: a global view
10.1038/nrgastro.2010.100 · 2010 · External reference
Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications
10.1097/01.sla.0000197706.21803.a1 · 2006 · External reference
Global cancer statistics
10.3322/caac.20107 · 2011 · External reference
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
10.1001/jama.295.1.65 · 2006 · External reference
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B
10.1002/hep.22884 · 2009 · External reference
Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis
10.1016/s0065-230x(09)03004-8 · 2009 · External reference
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma
10.1111/j.1440-1746.2010.06546.x · 2011 · External reference
Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development
10.1002/hep.24799 · 2012 · External reference
GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers
10.1371/journal.pgen.1002791 · 2012 · External reference
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
10.1371/journal.pone.0039175 · 2012 · External reference
Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients
10.1016/j.yexmp.2013.08.005 · 2013 · External reference
Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients
2014 · External reference
Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population
10.1371/journal.pone.0077315 · 2013 · External reference
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma
10.1038/ng.2483 · 2013 · External reference
A genome-wide association study identified new variants associated with the risk of chronic hepatitis B
10.1093/hmg/ddt266 · 2013 · External reference
Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients
10.1371/journal.pone.0080445 · 2014 · External reference
+49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population
10.1016/j.humimm.2009.09.353 · 2010 · External reference
Association of interferon-alpha gene polymorphisms with chronic hepatitis B virus infection
10.1111/iji.12055 · 2013 · External reference
Genetic polymorphism of interleukin-6 influences susceptibility to HBV-related hepatocellular carcinoma in a male Chinese Han population
10.1016/j.humimm.2014.02.006 · 2014 · External reference
Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma
10.1007/s12307-012-0111-1 · 2012 · External reference
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
10.1126/science.1840703 · 1991 · External reference
Tumor antigens recognized by T lymphocytes
10.1146/annurev.iy.12.040194.002005 · 1994 · External reference
Molecular mechanisms regulating Th1 immune responses
10.1146/annurev.immunol.21.120601.140942 · 2003 · External reference
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
10.1126/science.1129139 · 2006 · External reference
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
10.1371/journal.pone.0039179 · 2012 · External reference
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
10.1053/j.gastro.2007.03.102 · 2007 · External reference
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma
10.1007/s00432-010-0833-8 · 2010 · External reference
Viral clearance without destruction of infected cells during acute HBV infection
10.1126/science.284.5415.825 · 1999 · External reference
Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis
10.1172/jci118427 · 1996 · External reference
CD4+ CD25 +regulatory T cells correlate with chronic hepatitis B infection
10.1111/j.1365-2567.2007.02691.x · 2008 · External reference
Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice
10.1002/hep.25765 · 2012 · External reference
TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma
10.1016/j.ccr.2012.07.023 · 2012 · External reference
Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice
10.1073/pnas.1306437110 · 2013 · External reference
The dendritic cell system and its role in immunogenicity
10.1146/annurev.iy.09.040191.001415 · 1991 · External reference
Tumor antigen presentation: changing the rules
10.1007/s002620050463 · 1998 · External reference
Coronary sinus pressure and arterial venting do not affect retrograde cardioplegia distribution
10.1016/0003-4975(94)91943-7 · 1994 · External reference
Plasmacytoid dendritic cells in immunity
10.1038/ni1141 · 2004 · External reference
Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer
10.1684/ejd.2010.0816 · 2010 · External reference
Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma
10.1016/j.humpath.2005.11.007 · 2006 · External reference
The Janus face of dendritic cells in cancer
10.1038/onc.2008.270 · 2008 · External reference
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
10.1038/nm1201-1339 · 2001 · External reference
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer
2003 · External reference
Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage
10.4049/jimmunol.178.5.2763 · 2007 · External reference
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
10.1084/jem.20061660 · 2007 · External reference
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells
10.1371/journal.pone.0026315 · 2011 · External reference
Prognostic significances of tumor-infiltrating S-100 positive dendritic cells and lymphocytes in patients with hepatocellular carcinoma
2003 · External reference
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma
10.1007/s00432-006-0075-y · 2006 · External reference
Immune surveillance by the liver
10.1038/ni.2691 · 2013 · External reference
PD-1 inhibits antiviral immunity at the effector phase in the liver
10.1084/jem.20022235 · 2003 · External reference
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
10.1002/hep.22395 · 2008 · External reference
Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection
10.1002/hep.23226 · 2009 · External reference
Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta1 over pro-inflammatory cytokines
10.1016/j.dld.2011.11.005 · 2012 · External reference
The role of Kupffer cells in hepatitis B and hepatitis C virus infections
10.1016/j.jhep.2014.04.026 · 2014 · External reference
Liver fibrosis
10.1042/bj20071570 · 2008 · External reference
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection
10.1053/j.gastro.2011.06.063 · 2011 · External reference
Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis
10.1111/j.1600-0676.1998.tb00823.x · 1998 · External reference
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection
10.1046/j.1365-2893.2003.00412.x · 2003 · External reference
Role of Kupffer cells in the pathogenesis of liver disease
10.3748/wjg.v12.i46.7413 · 2006 · External reference
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
10.1016/j.cell.2005.04.014 · 2005 · External reference
Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma
10.1073/pnas.91.26.12808 · 1994 · External reference
Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages
10.1371/journal.ppat.1004032 · 2014 · External reference
Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor
10.1099/0022-1317-83-6-1281 · 2002 · External reference
Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line
1996 · External reference
Expression of different isoforms of TGF-beta and the latent TGF-beta binding protein (LTBP) by rat Kupffer cells
10.1016/s0168-8278(98)80119-0 · 1998 · External reference
Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes
10.1016/s0006-291x(02)02243-x · 2002 · External reference
Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1
10.1016/j.jhep.2005.02.033 · 2005 · External reference
HBsAg inhibits IFN-α production in plasmacytoid dendritic cells through TNF-α and IL-10 induction in monocytes
10.1371/journal.pone.0044900 · 2012 · External reference
Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation
10.4049/jimmunol.1201625 · 2013 · External reference
Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
10.1007/s00595-011-0058-8 · 2011 · External reference
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
10.1084/jem.20082173 · 2009 · External reference
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
10.1002/hep.25777 · 2012 · External reference
Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection
10.1245/s10434-013-3445-0 · 2014 · External reference
Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes
10.1016/s0168-8278(98)80206-7 · 1998 · External reference
Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C
10.1016/j.jhep.2009.05.030 · 2009 · External reference
Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections
10.1053/j.gastro.2009.05.047 · 2009 · External reference
The trafficking of natural killer cells
10.1111/j.1600-065x.2007.00563.x · 2007 · External reference
Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C
10.1136/gut.2005.076463 · 2006 · External reference
Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants
10.1111/jvh.12089 · 2013 · External reference
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
10.1016/j.jhep.2009.12.005 · 2010 · External reference
Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection
10.1371/journal.ppat.1001227 · 2010 · External reference
Fibrosis-dependent mechanisms of hepatocarcinogenesis
10.1002/hep.25670 · 2012 · External reference
Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma
10.1186/1756-9966-32-22 · 2013 · External reference
Liver sinusoidal endothelial cells and liver regeneration
10.1172/jci66025 · 2013 · External reference
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
10.1002/hep.22351 · 2008 · External reference
TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts
10.1016/j.mod.2012.09.003 · 2013 · External reference
Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines
10.1186/1756-9966-32-51 · 2013 · External reference
Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat
10.1126/science.1244880 · 2014 · External reference
The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity
10.1152/ajpgi.00167.2007 · 2008 · External reference
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
10.1002/hep.510230309 · 1996 · External reference
Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis
10.1158/0008-5472.can-05-2412 · 2006 · External reference
Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells
10.1159/000109079 · 2008 · External reference
Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma
2004 · External reference
The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus
10.1007/s12032-008-9130-7 · 2009 · External reference
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus
10.1245/s10434-010-0940-4 · 2010 · External reference
Tumor promotion via injury- and death-induced inflammation
10.1016/j.immuni.2011.09.006 · 2011 · External reference
Chemotaxis in cancer
10.1038/nrc3078 · 2011 · External reference
Accessories to the crime: functions of cells recruited to the tumor microenvironment
10.1016/j.ccr.2012.02.022 · 2012 · External reference
Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
10.1016/j.ccr.2008.06.016 · 2008 · External reference
Hepatocyte IKKβ/NF-κB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation
10.1016/j.ccr.2009.12.048 · 2010 · External reference
Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
10.1073/pnas.0603499103 · 2006 · External reference
Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells
10.1002/hep.23291 · 2009 · External reference
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
10.1002/hep.25572 · 2012 · External reference
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2014 · External reference
Hepatoprotection via the IL-6/Stat3 pathway
10.1172/jci19974 · 2003 · External reference
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
10.1126/science.1140485 · 2007 · External reference
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling
10.1073/pnas.0705395105 · 2008 · External reference
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression
10.1016/j.cell.2009.12.052 · 2010 · External reference
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling
10.1016/j.cell.2013.09.031 · 2013 · External reference
Non-cell-autonomous tumor suppression by p53
10.1016/j.cell.2013.03.020 · 2013 · External reference
NF-kB functions as a tumour promoter in inflammation-associated cancer
10.1038/nature02924 · 2004 · External reference
A lymphotoxin-driven pathway to hepatocellular carcinoma
10.1016/j.ccr.2009.08.021 · 2009 · External reference
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
10.1136/gutjnl-2011-301116 · 2012 · External reference
Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis
10.1016/j.ajpath.2011.05.005 · 2011 · External reference
Fas/FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease
10.1111/j.1365-2893.2008.00974.x · 2008 · External reference
miR-22 promotes HBV-related hepatocellular carcinoma development in males
10.1158/1078-0432.ccr-10-1734 · 2011 · External reference
Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system
10.3748/wjg.v9.i12.2671 · 2003 · External reference
Transfection of apoptosis related gene Fas ligand in human hepatocellular carcinoma cells and its significance in apoptosis
10.3748/wjg.v11.i17.2653 · 2003 · External reference
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma
10.1016/j.ejso.2006.10.036 · 2007 · External reference
B7-H1 up-regulated expression in human hepatocellular carcinoma tissue: correlation with tumor interleukin-10 levels
2011 · External reference
Decreased CD27 on B lymphocytes in patients with primary hepatocellular carcinoma
10.1177/147323001204000131 · 2012 · External reference
Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease
2000 · External reference
Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus
10.1016/s1386-6532(02)00271-8 · 2003 · External reference
The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection
10.1155/mi/2006/78380 · 2006 · External reference
Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients
10.1111/j.1478-3231.2011.02742.x · 2012 · External reference
Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma
10.3748/wjg.v13.i32.4345 · 2007 · External reference
Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma
2009 · External reference
Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma
10.1016/s0165-2478(02)00176-1 · 2002 · External reference
Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis
10.1152/ajpgi.00058.2011 · 2011 · External reference
Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells
1998 · External reference
Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection
10.1016/s0168-8278(02)00181-2 · 2002 · External reference
Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma
2007 · External reference
Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro
10.1111/j.1365-2249.2006.03281.x · 2007 · External reference
[Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]
10.3350/kjhep.2008.14.2.185 · 2008 · External reference
Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study
10.1007/s10585-009-9283-6 · 2009 · External reference
Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas
1991 · External reference
Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study
10.1111/j.1440-1827.1994.tb01697.x · 1994 · External reference
Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma: an in situ hybridization and immunohistochemical study
10.1097/00019606-199403010-00010 · 1994 · External reference
Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma
1995 · External reference
Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection
10.1016/j.cdp.2005.12.004 · 2006 · External reference
[Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma]
2012 · External reference
[Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis]
2013 · External reference
Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma
10.1016/j.dld.2006.10.015 · 2007 · External reference
Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection
10.1111/j.1742-1241.2007.01368.x · 2008 · External reference
The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma
10.1007/s00432-009-0629-x · 2010 · External reference
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
10.1002/hep.24703 · 2012 · External reference
Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin
10.1245/s10434-011-1946-2 · 2012 · External reference
Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma
10.1038/labinvest.2010.147 · 2010 · External reference
The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4
10.1038/sj.onc.1201760 · 1998 · External reference
Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 (IGF2) gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma
2014 · External reference
Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin
10.1099/vir.0.19650-0 · 2004 · External reference
Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma
10.1371/journal.pone.0041931 · 2012 · External reference
Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells
10.1002/hep.25899 · 2012 · External reference
Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B
10.1002/hep.22765 · 2009 · External reference
Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling
10.1016/j.canlet.2010.09.018 · 2011 · External reference
Hepatitis B virus X protein stimulates the Hedgehog-Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells
10.1016/j.canlet.2011.05.033 · 2011 · External reference
Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1
1998 · External reference
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
10.1186/1756-9966-28-58 · 2009 · External reference
Microenvironmental regulation of cancer metastasis by miRNAs
10.1016/j.tcb.2013.09.007 · 2014 · External reference
MicroRNAs in the tumour microenvironment: big role for small players
10.1530/erc-13-0119 · 2013 · External reference
Roles of microRNAs in the hepatitis B virus infection and related diseases
10.3390/v5112690 · 2013 · External reference
MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
10.1155/2014/486407 · 2014 · External reference
MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects
10.3748/wjg.v20.i20.5973 · 2014 · External reference
Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
10.1007/s13277-013-1141-0 · 2014 · External reference
Hepatocellular carcinoma pathogenesis: from genes to environment
10.1038/nrc1934 · 2006 · External reference
Microenvironmental regulation of metastasis
10.1038/nrc2618 · 2008 · External reference
Regulation of cancer cell metabolism
10.1038/nrc2981 · 2011 · External reference
Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells
10.1002/hep.24108 · 2011 · External reference
Hypoxia and the extracellular matrix: drivers of tumour metastasis
10.1038/nrc3726 · 2014 · External reference
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
10.1200/jco.2007.14.8288 · 2008 · External reference
Enhancement of antitumor immunity by CTLA-4 blockade
10.1126/science.271.5256.1734 · 1996 · External reference
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
10.1056/nejmoa1200694 · 2012 · External reference
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells
10.1126/scitranslmed.3003761 · 2012 · External reference
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
10.1056/nejmoa1200690 · 2012 · External reference
Breakthrough of the year 2013. Cancer immunotherapy
10.1126/science.342.6165.1432 · 2013 · External reference
Nivolumab plus ipilimumab in advanced melanoma
10.1056/nejmoa1302369 · 2013 · External reference
